Search research articles
Contact Us
Filters
Showing results (421-430 of 434) with videos related to
Page
of 44
Sort By:
International Journal of Molecular Sciences
|
June 26, 2025
<i>HSD3B1</i> (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers
Nikitha Vobugari, Allison Makovec, Samuel Kellen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2020
The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer
Artur A Serebrenik, Prokopios P Argyris, Matthew C Jarvis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 6, 2006
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection
Yueh-Ming Loo, David M Owen, Kui Li, et al.
Bioconjugate Chemistry
|
April 9, 2017
Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates
Xiuxia Sun, Jose F Ponte, Nicholas C Yoder, et al.
Elife
|
June 4, 2021
Multiplexed proteomics of autophagy-deficient murine macrophages reveals enhanced antimicrobial immunity via the oxidative stress response
Timurs Maculins, Erik Verschueren, Trent Hinkle, et al.
Cancer Research
|
March 4, 2010
Antibody-maytansinoid conjugates designed to bypass multidrug resistance
Yelena V Kovtun, Charlene A Audette, Michele F Mayo, et al.
Cell
|
January 25, 2020
Quantitative Proteomics of the Cancer Cell Line Encyclopedia
David P Nusinow, John Szpyt, Mahmoud Ghandi, et al.
Molecular Cancer Therapeutics
|
May 20, 2016
A New Triglycyl Peptide Linker for Antibody-Drug Conjugates (ADCs) with Improved Targeted Killing of Cancer Cells
Rajeeva Singh, Yulius Y Setiady, Jose Ponte, et al.
Molecular Cancer Therapeutics
|
March 16, 2021
Calicheamicin Antibody-Drug Conjugates with Improved Properties
Breanna S Vollmar, Chris Frantz, Melissa M Schutten, et al.
JCI Insight
|
April 1, 2025
Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma
Usha S Polaki, Trey E Gilpin, Apoorva T Patil, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 434) with videos related to
Sort By:
Page
of 44
International Journal of Molecular Sciences
|
June 26, 2025
<i>HSD3B1</i> (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers
Nikitha Vobugari, Allison Makovec, Samuel Kellen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2020
The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer
Artur A Serebrenik, Prokopios P Argyris, Matthew C Jarvis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 6, 2006
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection
Yueh-Ming Loo, David M Owen, Kui Li, et al.
Bioconjugate Chemistry
|
April 9, 2017
Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates
Xiuxia Sun, Jose F Ponte, Nicholas C Yoder, et al.
Elife
|
June 4, 2021
Multiplexed proteomics of autophagy-deficient murine macrophages reveals enhanced antimicrobial immunity via the oxidative stress response
Timurs Maculins, Erik Verschueren, Trent Hinkle, et al.
Cancer Research
|
March 4, 2010
Antibody-maytansinoid conjugates designed to bypass multidrug resistance
Yelena V Kovtun, Charlene A Audette, Michele F Mayo, et al.
Cell
|
January 25, 2020
Quantitative Proteomics of the Cancer Cell Line Encyclopedia
David P Nusinow, John Szpyt, Mahmoud Ghandi, et al.
Molecular Cancer Therapeutics
|
May 20, 2016
A New Triglycyl Peptide Linker for Antibody-Drug Conjugates (ADCs) with Improved Targeted Killing of Cancer Cells
Rajeeva Singh, Yulius Y Setiady, Jose Ponte, et al.
Molecular Cancer Therapeutics
|
March 16, 2021
Calicheamicin Antibody-Drug Conjugates with Improved Properties
Breanna S Vollmar, Chris Frantz, Melissa M Schutten, et al.
JCI Insight
|
April 1, 2025
Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma
Usha S Polaki, Trey E Gilpin, Apoorva T Patil, et al.
Page
of 44